We further validated the antitumor efficacy of NKTR-214 in a AH-1 antigenic peptide vaccine model of large CT26 tumors23, where we observe enhanced tumor control of single-dose peptide vaccine plus NKTR-214 compared with vaccine or NKTR-214 alone (Supplementary Fig. 3a–c). Here, NKTR is linked to neoplasm.